Photo from Richard Paxman/LinkedIn
Aug 25, 2024, 19:47
Paxman Scalp Cooling’s Q2 2024 report
Paxman Scalp Cooling posted on LinkedIn:
“We are delighted to share our Q2 2024 report!
Richard Paxman shared Paxman Scalp Cooling’s post adding:
“Congratulations Team Paxman on yet another strong quarter, the best yet! Feel very lucky to work with such impressive colleagues delivering strong results with a real purpose and impact! Strong top line growth, stable cost base and impressive EBITDA whilst making a difference around the world.”
Source: Paxman Scalp Cooling/LinkedIn and Richard Paxman/LinkedIn
Richard Paxman is the Chief Medical Officer and Managing Director at Paxman. Previously, he was an Operations Director at Paxman Coolers Limited. He has also served as the General Manager at Brewfitt Limited.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
An exciting quarter with the publications of important papers relating to both CPIN and scalp cooling as well as a record quarter, delivering sustainable top-line growth.
Read the full report below.”